Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robb E Wilentz

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Human Pathology|October 16, 2002
Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabelingMichael Torbenson, Spyridon Marinopoulos, Duyen T Dang, et al.
Cancer Chemotherapy and Pharmacology|June 16, 2004
Systemic BCNU enhances the efficacy of local delivery of a topoisomerase I inhibitor against malignant gliomaPhillip B Storm, Violette M Renard, John L Moriarity, et al.
International Journal of Gastrointestinal Cancer|February 22, 2005
HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tractDonna E Hansel, Ayman Rahman, Robb E Wilentz, et al.
American Journal of Clinical Pathology|July 2, 2002
K-ras, p53, and DPC4 (MAD4) alterations in fine-needle aspirates of the pancreas: a molecular panel correlates with and supplements cytologic diagnosisTjarda van Heek, Anne E Rader, G Johan A Offerhaus, et al.
The American Journal of Surgical Pathology|December 28, 2002
Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all 'chronic pancreatitis'?Susan C Abraham, Robb E Wilentz, Charles J Yeo, et al.
The American Journal of Pathology|May 10, 2002
Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinomaNoriyoshi Fukushima, Norihiro Sato, Takashi Ueki, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 11, 2003
Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline casesDenis M McCarthy, Anirban Maitra, Pedram Argani, et al.
The American Journal of Surgical Pathology|December 6, 2003
p16 Inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitisChristophe Rosty, Joseph Geradts, Norihiro Sato, et al.
American Journal of Clinical Pathology|August 7, 2002
Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imagingAnirban Maitra, Raheela Ashfaq, Carla R Gunn, et al.
The American Journal of Pathology|April 12, 2002
Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutationsSusan C Abraham, David S Klimstra, Robb E Wilentz, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Human Pathology|October 16, 2002
Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabelingMichael Torbenson, Spyridon Marinopoulos, Duyen T Dang, et al.
Cancer Chemotherapy and Pharmacology|June 16, 2004
Systemic BCNU enhances the efficacy of local delivery of a topoisomerase I inhibitor against malignant gliomaPhillip B Storm, Violette M Renard, John L Moriarity, et al.
International Journal of Gastrointestinal Cancer|February 22, 2005
HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tractDonna E Hansel, Ayman Rahman, Robb E Wilentz, et al.
American Journal of Clinical Pathology|July 2, 2002
K-ras, p53, and DPC4 (MAD4) alterations in fine-needle aspirates of the pancreas: a molecular panel correlates with and supplements cytologic diagnosisTjarda van Heek, Anne E Rader, G Johan A Offerhaus, et al.
The American Journal of Surgical Pathology|December 28, 2002
Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all 'chronic pancreatitis'?Susan C Abraham, Robb E Wilentz, Charles J Yeo, et al.
The American Journal of Pathology|May 10, 2002
Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinomaNoriyoshi Fukushima, Norihiro Sato, Takashi Ueki, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 11, 2003
Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline casesDenis M McCarthy, Anirban Maitra, Pedram Argani, et al.
The American Journal of Surgical Pathology|December 6, 2003
p16 Inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitisChristophe Rosty, Joseph Geradts, Norihiro Sato, et al.
American Journal of Clinical Pathology|August 7, 2002
Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imagingAnirban Maitra, Raheela Ashfaq, Carla R Gunn, et al.
The American Journal of Pathology|April 12, 2002
Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutationsSusan C Abraham, David S Klimstra, Robb E Wilentz, et al.
Pageof 3